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Monocyte gene expression in 
childhood obesity is associated 
with obesity and complexity of 
atherosclerosis in adults
G. C. Keustermans1, D. Kofink2, A. Eikendal3,4, W. de Jager  1, J. Meerding1, R. Nuboer5,  
J. Waltenberger6, A. O. Kraaijeveld2, J. W. Jukema7, J. W. Sels8, J. Garssen9,10, B. J. Prakken1,11, 
F. W. Asselbergs  2,12,13, E. Kalkhoven14, I. E. Hoefer3, G. Pasterkamp3 & H. S. Schipper  1,11,15
Childhood obesity coincides with increased numbers of circulating classical CD14++CD16- and 
intermediate CD14++CD16+ monocytes. Monocytes are key players in the development and 
exacerbation of atherosclerosis, which prompts the question as to whether the monocytosis in childhood 
obesity contributes to atherogenesis over the years. Here, we dissected the monocyte gene expression 
profile in childhood obesity using an Illumina microarray platform on sorted monocytes of 35 obese 
children and 16 lean controls. Obese children displayed a distinctive monocyte gene expression profile 
compared to lean controls. Upon validation with quantitative PCR, we studied the association of the top 
5 differentially regulated monocyte genes in childhood obesity with obesity and complexity of coronary 
atherosclerosis (SYNTAX score) in a cohort of 351 adults at risk for ischemic cardiovascular disease. 
The downregulation of monocyte IMPDH2 and TMEM134 in childhood obesity was also observed in 
obese adults. Moreover, downregulation of monocyte TMEM134 was associated with a higher SYNTAX 
atherosclerosis score in adults. In conclusion, childhood obesity entails monocyte gene expression 
alterations associated with obesity and enhanced complexity of coronary atherosclerosis in adults.
The childhood obesity epidemic has alarming cardiovascular consequences, and thereby limits the worldwide 
increase in life expectancy1,2. Obesity early in life may contribute to the development of cardiovascular disease 
in several ways. First, childhood obesity tends to result in adulthood obesity, which is an important risk factor 
for cardiovascular disease, especially when it concerns visceral adiposity3,4. Second, childhood and adulthood 
obesity share independent risk factors for cardiovascular disease, such as a high blood pressure5. Furthermore, 
obesity-induced insulin resistance and hyperglycemia lead to defective insulin signaling in vascular wall lesional 
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cells, which promotes atherosclerosis at the level of the arterial wall6. Finally, obesity is associated with low-grade 
systemic inflammation, which promotes atherogenesis7,8.
At a cellular level, monocytes appear to be a pivotal link between obesity and cardiovascular disease. Obesity 
is accompanied by leukocytosis, particularly of the myeloid lineage7,9. Recent studies indicate that adipose tissue 
derived inflammatory factors such as IL-1β stimulate bone marrow myeloid progenitors, leading to monocy-
tosis in obesity10. Next to increased numbers, monocytes show an activated and inflammatory phenotype in 
obesity. In humans, monocytes fall into three phenotypical categories: classical CD14++CD16−, intermediate 
CD14++CD16+ and nonclassical CD14+CD16++ monocytes11. Previously, we have shown that childhood obesity 
is accompanied by increased numbers and an activated phenotype of the classical CD14++CD16− monocyte 
subset7. These monocytes are equivalent to GR1+Ly6chigh monocytes in mice, that differentiate into inflammatory 
macrophages and foam cells in various atherosclerosis models12,13. The increased inflammatory monocyte num-
bers in childhood obesity may thus contribute to atherogenesis over the years.
The aim of this study was to obtain in-depth understanding of the monocyte gene expression profile in 
childhood obesity as compared to normal weight controls using micro-array analyses of sorted monocytes. 
Furthermore, monocyte gene expression profiles were compared with an established cohort of 351 adults at risk 
for ischemic cardiovascular disease, to study whether monocyte gene expression profiles in childhood obesity 
overlap with an atherogenic monocyte phenotype in adults. The adult cohort encompassed several clinical param-
eters, but we focused on the relation between monocyte gene expression and the SYNTAX atherosclerosis score 
because it is an established angiographic grading system for evaluating the complexity of coronary atherosclerotic 
lesions, widely used as a readout for atherosclerotic burden14–18.
Results
Monocytes in childhood obesity show a distinctive gene expression profile. Obese children 
exhibited typical clinical and biochemical characteristics with a significantly higher Body Mass Index stand-
ard deviation for age and sex (BMI-SD) compared to lean controls (3.4 versus 0.4, p < 0.001), a higher systolic 
blood pressure (BP) (123 mmHg, versus 110 mmHg, p = 0.005), lower Quantitative insulin sensitivity index 
(QUICKI) (0.3 versus 0.4, p < 0.001) and lower High-density lipoprotein (HDL) cholesterol level (1.2 mmol/L 
versus 1.5 mmol/L, p = 0.004) (Table 1). Furthermore, the obese subgroup showed a higher total monocyte num-
ber (0.6 × 109/ml versus 0.4 × 109/ml, p < 0.001), reflecting a higher classical CD14++CD16− monocyte num-
ber (52.0 × 107/ml vs. 36.2 × 107/ml, p = 0.001) and a higher intermediate CD14++CD16+ monocyte number 
(4.6 × 107/ml versus 3.3 × 107/ml, p < 0.001). Notably, the obese population showed a higher age compared to 
the lean controls (13.9 versus 10.5 years), and a lower percentage of boys (31% versus 44%). In order to avoid 
confounding, all subsequent analyses were corrected for age and sex.
Following microarray multiple testing correction, 67 genes were significantly and differently expressed 
between the obese and lean participants (Supplemental Tables 1 and 2). An unbiased clustering approach revealed 
a clear separation in monocyte gene expression profiles between lean and obese individuals (Fig. 1). The microar-
ray data thus highlighted a distinctive monocyte gene expression profile in obese children.
Quantitative PCR validation. Quantitative PCR (qPCR) was used to confirm the gene expression results, 
focusing on the top 20 microarray hits. qPCR analyses confirmed the observed downregulation of the monocyte 
genes Hydroxymethylbilane synthase (HMBS) (p = 0.01), Leucine Rich Pentatricopeptide Repeat Containing 
(LRPPRC) (p = 0.005), Transmembrane protein 134 (TMEM134) (p = 0.028) and Zwilch Kinetochore Protein 
(ZWILCH) (p = 0.005) in childhood obesity compared to lean controls (Fig. 2, Supplemental Table 7). 
Furthermore, Inosine Monophosphate Dehydrogenase 2 (IMPDH2) showed a trend towards downregulation in 
obese monocytes (p = 0.06). Because of its significant downregulation in monocytes from obese adults, IMPDH2 
was included in subsequent analyses as well. Together, these 5 downregulated genes formed the starting point for 
subsequent studies. First, the association between the 5 downregulated monocyte genes and a selection of clinical 
Lean children (n = 16) Obese children (n = 35)
Age (years) 10.5 (8.4, 12.9)* 13.9 (10.8, 14.9)*
Boys (number, %) 7 (44) 11 (31)
BMI-SD 0.4 (−0.7, 0.9)§ 3.4 (3.1, 3.7)§
QUICKI 0.4 (0.3, 0.4)§ 0.3 (0.3, 0.3)§
Systolic blood pressure (SBP, mmHg) 110 (98, 120)§ 123 (113, 129)§
HDL-cholesterol (mmol/L) 1.5 (1.3, 1.7)§ 1.2 (1.0, 1.4)§
LDL-cholesterol (mmol/L) 2.2 (2.2, 2.4) 2.3 (2.0, 3.0)
Triglycerides (mmol/L) 0.7 (0.5, 0.9) 0.9 (0.7, 1.3)
Total monocyte number (x 109) 0.4 (0.4, 0.5)§ 0.6 (0.5, 0.7)§
CD14++CD16− monocyte number (x 107) 36.2 (34.3, 43.2)§ 52.0 (43.3, 64.7)§
CD14++CD16+ monocyte number (x 107) 1.8 (1.2, 2.3)§ 4.6 (3.0, 7.0)§
Table 1. Characteristics of the pediatric study population Clinical characteristics and laboratory parameters 
for lean controls versus obese children. Data is shown as median (interquartile range). *p < 0.05, §p < 0.01. 
BMI-SD: standard deviation of body mass index corrected for age and sex, HDL: high-density lipoprotein, LDL: 
low-density lipoprotein, QUICKI: quantitative insulin sensitivity index.
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variables in childhood was explored (Supplemental Tables 3 and 4). Second, the association with obesity and 
atherosclerosis was studied in an adult cohort at risk for ischemic cardiovascular disease.
Pathway analysis. Focusing on the functional relevance of the observed gene expression profile, the func-
tional enrichment of the differentially expressed genes in biological processes was assessed using ToppFun, a 
GO Term enrichment tool. Sixty-four out of 67 genes could be identified by ToppFun and were mapped to path-
ways involved in biological processes, using a minimum pathway size of 10 genes. These genes were particularly 
involved in oxidative phosphorylation and distinct metabolic processes (Supplemental Table 5, Supplemental 
Fig. 1).
Monocyte gene expression and adult obesity and cardiovascular risk. To investigate whether 
adults at risk show a monocyte gene expression profile similar to obese children, the 5 validated monocyte genes 
were studied in a cohort of 351 adults at risk for ischemic cardiovascular disease. Clinical characteristics of the 
adult cohort are provided in Supplemental Table 8.
Downregulation of monocyte IMPDH2 (β = −0.496, p = 0.004) and TMEM134 (β = −0.314, p = 0.043) 
was associated with obesity in adults (BMI >30 kg/m2), paralleling our findings in children. These relationships 
remained significant after adjustment for age and sex (Table 2). Next, we tested whether monocyte gene expres-
sion was associated with the established SYNTAX (Synergy between percutaneous coronary intervention with 
Taxus and Cardiac Surgery) coronary atherosclerosis score. The SYNTAX score uses coronary angiography find-
ings to quantify the complexity of coronary atherosclerosis, based on the number of atherosclerotic lesions, their 
location and their functional impact14. The Syntax score was originally developed to help clinicians select the 
most appropriate revascularization strategy, but is increasingly being used as a risk stratification tool for adverse 
ischemic events14,19. The SYNTAX score was available for 196 of the 351 adults. Monocyte TMEM134 downreg-
ulation was associated with higher SYNTAX scores (β = −0.247, p = 0.041) (Table 3). While adjustment of age 
and sex did not alter this association (β = −0.251, p = 0.033), addition of BMI to the model attenuated the asso-
ciated between TMEM134 expression and SYNTAX scores. In summary, monocyte TMEM134 downregulation 
is observed in childhood obesity, associated with obesity in adults at risk, and correlates with a higher SYNTAX 
score in adults at risk in an obesity-dependent fashion.
Figure 1. Heat map and cluster analysis of monocyte gene expression. The heat map depicts the gene cluster 
structure as a hierarchical tree with distinct branches and uses row z-score to depict data that deviates above or 
below the population mean.
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Discussion
Monocytes are key players in the development and exacerbation of atherosclerosis, both via their role as mac-
rophage foam cell precursors and their role in systemic inflammation20. In human studies, increased numbers 
of classical CD14++CD16− and intermediate CD14++CD16+ monocytes predict cardiovascular events inde-
pendent of age, sex and classical cardiovascular risk factors21,22. Interestingly, childhood obesity also coincides 
with increased circulating numbers of classical and intermediate monocytes7, which prompts the question as to 
whether the monocytosis in childhood obesity contributes to atherogenesis over the years. The atherogenic role of 
monocytes in childhood obesity is difficult to study in human models, since longitudinal data are lacking. To the 
best of our knowledge, this is the first monocyte gene expression study in childhood obesity, and the first endeavor 
to crosscheck gene expression profiles in adults at risk for ischemic cardiovascular disease. Our study showed a 
distinctive monocyte gene expression profile in childhood obesity, and downregulation of monocyte IMPDH2 
and TMEM134 was also associated with obesity in the adult cohort at risk. Finally, downregulated TMEM134 
coincided with a higher SYNTAX score in adults at risk, reflecting an enhanced atherosclerotic burden14,19.
Our results stress the relevance of the monocytosis in childhood obesity and raise several interesting ques-
tions. First, pathway analysis of differentially regulated monocyte genes in childhood obesity revealed an over-
representation of oxidative phosphorylation, oxidative stress, and intracellular metabolism pathways, which 
apparently reflects reprogramming to aerobic glycolysis. While resting immune cells primarily need ATP to meet 
cellular demands, and use glucose-pyruvate conversion (glycolysis) and oxidative phosphorylation to fulfill these 
needs, many immune cells in inflammatory microenvironments undergo metabolic reprogramming to aerobic 
glycolysis in order to engage in cellular growth and proliferation23. Interestingly, an upregulation of aerobic gly-
colysis also coincides with the development of ‘trained immunity’24. Upon repetitive stimulation with microbial 
moieties and/or metabolites, monocytes undergo epigenetic reprogramming towards aerobic glycolysis, which 
enhances the response of the trained monocytes in case of restimulation23,25. Recent literature suggests that the 
development of trained immunity contributes to the development of systemic inflammation and atherosclerosis, 
and represents an intriguing target for therapeutic intervention25.
Second, the role of TMEM134 in monocytes gains traction. In human monocyte studies, the expression of 
TMEM134 was decreased in classical CD14++CD16− and intermediate CD14++CD16+ monocytes, in contrast 
to nonclassical CD14+CD16++ monocytes26. Hence TMEM134 downregulation in childhood obesity and adults 
Figure 2. Quantitative PCR confirms downregulation of 5 monocyte genes in childhood obesity. Graphs show 
fold induction of the gene of interest, normalized for housekeeping gene expression. Error bars represent SEM.
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with cardiovascular risk may reflect obesity-induced CD14++CD16- and CD14++CD16+ monocytosis. Whether 
the highly conserved 21.5 kDa transmembrane protein TMEM134 plays an active role in monocyte differentiation 
remains to be elucidated. Notably, the existing studies indicate that TMEM134 affects the prototypical inflamma-
tory nuclear factor-κB (NF-κB) signaling pathway. TMEM 134 was identified as a binding protein of latent mem-
brane protein 1 (LMP1) and Hepatitis E Virus Open Reading Frame 2 (ORF2), and affected downstream NF-κB 
signalling via these binding partners27,28. Importantly, modulation of downstream NF-κB signalling is considered 
one of the hallmarks of innate immune programming in chronic inflammation29. Therefore, it is tempting to 
speculate that the observed downregulation of TMEM134 in childhood obesity monocytes is connected to the 
development of trained immunity, as discussed previously.
Finally, limitations of the current study have to be taken into account. Since our pediatric study population 
was relatively small, the associations reported in our study are of subtle strength. Second, environmental factors 
such as freeze-thawing of the monocytes may have influenced gene expression profiles. Though pediatric and 
adult samples were treated similarly, minor processing differences could impact gene expression profiles. Third, 
we chose to focus on the 5 qPCR-validated monocyte genes. Thereby, we may have disregarded important mono-
cyte genes that were not included in the qPCR validation. Finally, CD14-positive magnetic bead sorting skewed 
the analyzed monocyte compartments towards classical CD14++CD16− and intermediate CD14++CD16+ mono-
cytes (Supplemental Fig. 2), and partly disregarded the nonclassical CD14+CD16++ monocyte subset, which is 
considered less important for atherosclerosis development21,22.
In conclusion, childhood obesity entails monocyte gene expression alterations associated with obesity and 
enhanced complexity of coronary atherosclerosis in adults. Especially the role of TMEM134 in monocytes gains 
traction, as downregulation of monocyte TMEM134 was associated with obesity in children and adults, and coin-
cided with a higher SYNTAX atherosclerosis score in adults at risk for ischemic cardiovascular disease.
Methods
Pediatric cohort. Peripheral blood mononuclear cells (PBMC) were studied of 51 children aged 6–16 years 
(35 obese, 16 lean controls). The cells were derived from a previously published cross-sectional study at the 
Pediatric Outpatient Department of the Meander Medical Center in Amersfoort, the Netherlands, consisting 
of 60 obese children and 30 age- and sex-matched lean controls7. Because PBMC were available for 35 obese 
Gene ID Transcript Array ID
Model 1 Model 2
β (95% CI) β (95% CI)
HMBS ILMN_16358 6060278 −0.213 (−0.505, 0.078) −0.233 (−0.541, 0.076)
HMBS ILMN_16358 7320021 −0.194 (−0.496, 0.108) −0.227 (−0.549, 0.095)
IMPDH2 ILMN_3439 4590026 −0.424 (−0.753, −0.095)* −0.496 (−0.837, −0.156)§
LRPPRC ILMN_23753 6380064 −0.007 (−0.287, 0.272) −0.013 (−0.304, 0.277)
TMEM134 ILMN_176754 5690711 −0.061 (−0.318, 0.195) −0.068 (−0.340, 0.203)
TMEM134 ILMN_183533 670671 −0.311 (−0.610, −0.011)* −0.314 (−0.620, −0.009)*
ZWILCH ILMN_166966 7000743 −0.167 (−0.467, 0.133) −0.168 (−0.485, 0.148)
ZWILCH ILMN_3475 4850221 −0.247 (−0.556, 0.062) −0.260 (−0.581, 0.062)
Table 2. Monocyte gene expression and obesity in the adult cohort The association of the 5 monocyte genes 
with obesity in the adult cohort was studied using a logistic regression model. Adult obesity was defined as 
a BMI >30 kg/m2, according to international standards and compared to a normal weight BMI <25 kg/m2. 
Logistic regression coefficients β with 95% confidence intervals (95% CI) for the monocyte genes are shown, 
both unadjusted (model 1) and adjusted for age and sex (model 2). *p < 0.05, § p < 0.01.
Gene ID Transcript Array ID
Model 1 Model 2 Model 3
β (95% CI) β (95% CI) β (95% CI)
HMBS ILMN_16358 6060278 −0.005 (−0.243, 0.232) 0.002 (−0.232, 0.237) −0.013 (−0.252, 0.227)
HMBS ILMN_16358 7320021 −0.043 (−0.281, 0.195) −0.013 (−0.247, 0.221) −0.030 (−0.268, 0.208)
IMPDH2 ILMN_3439 4590026 −0.133 (−0.370, 0.104) −0.116 (−0.347, 0.115) −0.090 (−0.331, 0.150)
LRPPRC ILMN_23753 6380064 −0.187 (−0.424, 0.049) −0.188 (−0.419, 0.043) −0.201 (−0.437, 0.036)
TMEM134 ILMN_176754 5690711 −0.222 (−0.458, 0.014) −0.211 (−0.443, 0.021) −0.193 (−0.43, 0.044)
TMEM134 ILMN_183533 670671 −0.247 (−0.483, −0.012)* −0.251 (−0.481, −0.022)* −0.227 (−0.464, 0.011)
ZWILCH ILMN_166966 7000743 −0.102 (−0.339, 0.136) −0.171 (−0.404, 0.062) −0.168 (−0.408, 0.071)
ZWILCH ILMN_3475 4850221 0.030 (−0.207, 0.268) 0.010 (−0.223, 0.242) 0.048 (−0.197, 0.293)
Table 3. Monocyte gene expression and SYNTAX score in the adult cohort The association of the 5 validated 
genes with severity of coronary artery atherosclerosis (SYNTAX score, square-root transformed) was studied 
using linear regression. Linear regression coefficients β with 95% confidence intervals (95% CI) for the 
monocyte genes are shown. Model 1: unadjusted, model 2: adjusted for age and sex, model 3: adjusted for age, 
sex and BMI. *p < 0.05.
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children and 16 lean controls, these children were included in the current study. Importantly, the availability 
of stored PBMC depended on the amount of blood a patient donated upon inclusion, which varied randomly. 
Therefore, we believe patients in the current study are a random selection of the previous study.
BMI-SD was calculated using the outcomes of the Fifth Dutch Growth Study (2008–2010). Childhood obesity 
was defined as BMI-SD >2.5, which can be extrapolated toward the international definition of obesity as BMI 
>30 kg/m2 for adults30,31. Blood pressure was measured using an automated oscillometric method (Dinamap; GE 
Healthcare, Amersham, UK). Lipid profiles where obtained using standardized laboratory procedures. Written 
informed consent was obtained from all children and their parents. The study was approved by the Institutional 
Medical Ethical Review Board of the University Medical Center Utrecht, The Netherlands. All experiments with 
human biological materials were performed in accordance with the relevant guidelines and regulations.
Adult cohort. CTMM Circulating Cells is a multi-center cohort of four Dutch medical centers that enrolled 
patients with stable or unstable angina pectoris undergoing coronary angiography, with the aim of identifying 
cellular biomarkers for the prediction of adverse cardiovascular events. Patients were recruited between March 
2009 and September 2011. Details of the study design have been described elsewhere32. All participants provided 
written informed consent. The study was approved by the Institutional Medical Ethical Review Board of the 
University Medical Center Utrecht, The Netherlands. Data from 351 patients were included in the final analysis 
after removal of samples with outlying median intensity (Supplemental Table 8). Gene expression profiles were 
quantile-normalized followed by log2 transformation. The complexity of coronary atherosclerosis was assessed 
with coronary angiography using the SYNTAX score system. Two independent observers quantified SYNTAX 
scores, using SYNTAX score calculator version 2.11. The SYNTAX score is a tool for evaluating the complexity of 
coronary artery disease, taking into account the number of atherosclerotic lesions, their location and their func-
tional impact14. SYNTAX scores were available from 196 of the 351 patients.
Monocytes. In both cohorts, peripheral blood mononuclear cells (PBMC) were isolated using Ficoll-Paque 
density gradient centrifugation. In the pediatric cohort, flow cytometric phenotyping was performed in earlier 
studies7. Subsequent to isolation, samples were stored in freeze medium (FCS with 10% DMSO, Sigma-Aldrich) 
until further use. In order to isolate monocytes, stored samples where thawed and washed in medium compris-
ing of RPMI1640 supplemented with l-glutamate and 25 mM HEPES (Gibco), containing 2% FCS and penicil-
lin/streptomycin (100 U/mL) (Invitrogen). Cells where spun down for 10 min, 1600 rpm at room temperature. 
PBMCs where then resuspended in MACS buffer - 2%FBS (Biowest), 2%EDTA (VWR chemicals) in PBS (Gibco) 
- and counted using the trypan blue exclusion method (Gibco). Anti-human CD14 magnetic particles where sub-
sequently used to isolate monocytes using the company protocol (BD IMag). The CD14 positive cells were then 
re-suspended in 500ul of TRIZOL (Life Technologies) and stored at −80 °C.
Microarray and data processing. RNA was isolated from the trizol-lysed samples by AROS Applied 
Biotechnology. Samples of the 35 obese children and 16 healthy control children and the 351 adults underwent 
the same isolation procedures, and were similarly processed. In short, samples were labeled using the Illumina 
TotalPrep RNA Amplification Kit and 100 ng of total RNA. The IVT product was QC-checked on gel and quan-
titated using the NanoDrop (Thermo Scientific). 750 ng of cDNA was used for the standard Illumina protocol 
before samples were hybridized on the arrays (Illumina humanHT-12 v3). Arrays were scanned using a Bead 
Array Reader (Illumina). After inspection of the sample median intensities, samples with a median intensity of 
<50 were removed. Subsequently, the expression data was quantile-normalised and log2 transformed using the 
lumi R package33.
qPCR Validation. To validate the 67 differentially expressed genes, qPCR primers were designed for the top 
20 hits. Of these primer pairs 17 functioned optimally and were deemed applicable for the validation process 
(Supplementary Table 6). High quality RNA of 27 obese children and 11 healthy controls was available for the 
qPCR validation studies. qPCR analysis was performed using SYBR Select Master Mix reagents (Thermo Fischer 
Scientific) and run using the QuantStudio Flex system (Thermo Fischer Scientific). Data was normalized for 
housekeeping gene expression of GUSB, 36B4 and B2M, in accordance with international standards34.
Statistics. First, demographic characteristics of the study population were presented as numbers and per-
centages for categorical variables and as means with standard deviation (SD) or medians with interquartile ranges 
(Q1, Q3) for normal and non-normally distributed continuous variables, respectively. Subsequently, monocyte 
gene expression profiles of lean and obese children were compared and significant differences between both 
groups were assessed using Mann Whitney U tests for continuous variables and X2 test for binary variables.
Second, monocyte gene expression profiles were compared using the Limma package in R. In short, the 
Limma package uses empirical Baysian methods for the analysis of gene expression microarray data and is spe-
cifically designed for analyzing smaller datasets33. For this analysis, the genes functioned as outcome variables 
(dependent variables) and obesity status as determinant (independent variable). Age and sex were included in the 
model as covariates. In addition, to adjust for multiple testing, Benjamini Hochberg (BH) correction was applied. 
To illustrate the results of the microarray analysis, a heat map was generated using the heatmap.2 function in R. 
Hierarchical clustering was performed using complete linkage.
Third, linear regression was used to study the relation between obesity status and the gene expression (depend-
ent variable) For this analysis, two models were constructed; a crude model (Model 1) and a model in which age 
and sex were included as covariates (Model 2) (Supplemental Table 2).
Fourth, the relation between the 5 qPCR validated genes and clinical variables was studied in the whole pedi-
atric cohort (n = 51) as well as the obese subgroup (n = 35) and the adult cohort (n = 351) using linear regression 
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analysis (Supplemental Tables 3 and 4). For the analysis performed in the whole pediatric cohort age, sex and 
BMI-SD were included as covariates whereas for the analysis in the obese subgroup age and sex were included as 
covariates. P2-sided <0.05 was considered statistically significant.
Data availability. The pediatric datasets generated and analyzed during the current study are available from 
the corresponding author on reasonable request. Restrictions apply to data of the adult CTMM Circulating Cells 
dataset, which were used under license for the current study, and are not publicly available. Data are available 
from the authors upon reasonable request and after permission of the CTMM Circulating Cells consortium.
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